57 related articles for article (PubMed ID: 19160809)
21. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
22. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.
Yoshizaki T; Horikawa T; Qing-Chun R; Wakisaka N; Takeshita H; Sheen TS; Lee SY; Sato H; Furukawa M
Clin Cancer Res; 2001 Jul; 7(7):1946-51. PubMed ID: 11448908
[TBL] [Abstract][Full Text] [Related]
23. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
Huen DS; Henderson SA; Croom-Carter D; Rowe M
Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
[TBL] [Abstract][Full Text] [Related]
24. EBV latent membrane protein 1 is a negative regulator of TLR9.
Fathallah I; Parroche P; Gruffat H; Zannetti C; Johansson H; Yue J; Manet E; Tommasino M; Sylla BS; Hasan UA
J Immunol; 2010 Dec; 185(11):6439-47. PubMed ID: 20980631
[TBL] [Abstract][Full Text] [Related]
25. [Effects of Epstein-Barr virus latent membrane protein 1 mediated by nuclear factor-kappaB on transformation and tumorigenesis of rat-1 cells].
Zhang ZW; He ZM; Zhou M; Zhang Q; Yu YH; Chen ZC
Ai Zheng; 2007 Feb; 26(2):118-22. PubMed ID: 17298737
[TBL] [Abstract][Full Text] [Related]
26. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
Guiretti DM; Chabay PA; Valva P; Stefanoff CG; Barros MH; De Matteo E; Renault IZ; Preciado MV; Hassan R
J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
[TBL] [Abstract][Full Text] [Related]
27. [Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].
Wang C; Deng X; Li X; Gu H; Yi W; Weng X; Xia L; Cao Y
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):9-13. PubMed ID: 11977651
[TBL] [Abstract][Full Text] [Related]
28. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
Eliopoulos AG; Young LS
Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
[TBL] [Abstract][Full Text] [Related]
29. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.
Kim KR; Yoshizaki T; Miyamori H; Hasegawa K; Horikawa T; Furukawa M; Harada S; Seiki M; Sato H
Oncogene; 2000 Mar; 19(14):1764-71. PubMed ID: 10777210
[TBL] [Abstract][Full Text] [Related]
30. Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.
Terrin L; Dal Col J; Rampazzo E; Zancai P; Pedrotti M; Ammirabile G; Bergamin S; Rizzo S; Dolcetti R; De Rossi A
J Virol; 2008 Oct; 82(20):10175-87. PubMed ID: 18684838
[TBL] [Abstract][Full Text] [Related]
31. Caspase-dependent cleavage regulates protein levels of Epstein-Barr virus-derived latent membrane protein 1.
Togi S; Hatano Y; Muromoto R; Kawanishi E; Ikeda O; Hirashima K; Kon S; Kitai Y; Yasui T; Oritani K; Matsuda T
FEBS Lett; 2016 Mar; 590(6):808-18. PubMed ID: 26921582
[TBL] [Abstract][Full Text] [Related]
32. The LMP1 promoter can be transactivated directly by NF-kappaB.
Demetriades C; Mosialos G
J Virol; 2009 May; 83(10):5269-77. PubMed ID: 19279104
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9.
Bentz GL; Whitehurst CB; Pagano JS
J Virol; 2011 Oct; 85(19):10144-53. PubMed ID: 21795333
[TBL] [Abstract][Full Text] [Related]
34. Proteome analysis of the transformation potential of the Epstein-Barr virus-encoded latent membrane protein 1 in nasopharyngeal epithelial cells NP69.
Zhang Q; Zhang Z; Wang C; Xiao Z; Yu Y; Yang F; Chen Z; He Z
Mol Cell Biochem; 2008 Jul; 314(1-2):73-83. PubMed ID: 18425422
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation.
Bentz GL; Shackelford J; Pagano JS
J Virol; 2012 Nov; 86(22):12251-61. PubMed ID: 22951831
[TBL] [Abstract][Full Text] [Related]
36. Association of the Epstein-Barr virus latent membrane protein 1 with lipid rafts is mediated through its N-terminal region.
Rothenberger S; Rousseaux M; Knecht H; Bender FC; Legler DF; Bron C
Cell Mol Life Sci; 2002 Jan; 59(1):171-80. PubMed ID: 11846027
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes.
Tomita M; Dewan MZ; Yamamoto N; Kikuchi A; Mori N
Cancer Sci; 2009 May; 100(5):807-12. PubMed ID: 19309363
[TBL] [Abstract][Full Text] [Related]
38. Dissociation of patching by latent membrane protein-1 of Epstein-Barr virus from its stimulation of NF-kappaB activity.
Bloss T; Kaykas A; Sugden B
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3227-3232. PubMed ID: 10567655
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr Virus LMP1 Modulates the CD63 Interactome.
Cheerathodi M; Nkosi D; Cone AS; York SB; Meckes DG
Viruses; 2021 Apr; 13(4):. PubMed ID: 33920772
[TBL] [Abstract][Full Text] [Related]
40. Generation and characterization of a novel recombinant antibody against LMP1-TES1 of Epstein-Barr virus isolated by phage display.
Zhang D; Mao Y; Cao Q; Xiong L; Wen J; Chen R; Zhu J
Viruses; 2013 Apr; 5(4):1131-42. PubMed ID: 23609879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
